SCHEMBL13616009

SCHEMBL13616009

c1ccc(-c2ccc3c4ccc(-c5ccncc5)cc4c4c5ccccc5c5ccccc5c4c3c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.56
MKNK1 Q9BUB5 1/20 0.54
PIK3CA P42336 1/20 0.53
IMPDH2 P12268 1/20 0.51
CHEK1 O14757 3/20 0.44
ALK Q9UM73 1/20 0.44
CDK1 P06493 1/20 0.42
CDK4 P11802 1/20 0.42
CCNA2 P20248 1/20 0.42
CCND1 P24385 1/20 0.42
CDK2 P24941 1/20 0.42
CCND3 P30281 1/20 0.42
DHODH Q02127 1/20 0.42
QDPR P09417 1/20 0.41
MAPT P10636 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
JAK2 O60674 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13615950 0.96 MKNK1 (0.49) NOTUMMKNK1PIK3CAIMPDH2CHEK1
SCHEMBL13615921 0.96 MKNK1 (0.49) NOTUMMKNK1PIK3CAIMPDH2CHEK1
SCHEMBL13615771 0.96 MKNK1 (0.49) NOTUMMKNK1PIK3CAIMPDH2CHEK1
SCHEMBL24741392 0.93 MKNK1 (0.46) NOTUMMKNK1PIK3CAIMPDH2CHEK1
SCHEMBL13615875 0.88 MAPT (0.52) NOTUMMKNK1PIK3CAIMPDH2ALK
SCHEMBL17343982 0.87 NOTUM (0.58) NOTUMMKNK1PIK3CAIMPDH2CHEK1
SCHEMBL17343980 0.87 NOTUM (0.58) NOTUMMKNK1PIK3CAIMPDH2CHEK1
SCHEMBL16641378 0.87 NOTUM (0.58) NOTUMMKNK1PIK3CAIMPDH2CHEK1
SCHEMBL17343934 0.87 NOTUM (0.58) NOTUMMKNK1PIK3CAIMPDH2CHEK1
SCHEMBL17343948 0.87 NOTUM (0.58) NOTUMMKNK1PIK3CAIMPDH2CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090273278-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed
US-20090273278-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090273278-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 NOTUM 74/4885MKNK1 4653/4885PIK3CA 3332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.